-
CRN adds food and drug law policy expert to staff
WASHINGTON — The Council for Responsible Nutrition on Monday announced that Rend Al-Mondhiry has joined CRN’s staff to serve as the trade association’s regulatory counsel.
“This is a new position for our association and [Al-Mondhiry's] skill set and experience provide a perfect match for what we need," CRN president and CEO Steve Mister said. "Her knowledge of food and drug law will make her a tremendous asset for our staff and for our members."
-
FDA approves Erwinaze for acute lymphoblastic leukemia
SILVER SPRING, Md. — The Food and Drug Administration has approved a new chemotherapy drug for treating acute lymphoblastic leukemia, the agency said Friday.
The FDA announced the approval of EUSA Pharma's Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with ALL who have developed an allergy to E. coli-derived asparaginase and pegaspargase chemotherapy drugs.